Belatacept Transplant Drug Offers Hope for Preserving Kidney Function
Today, kidney transplantation provides patients with invaluable benefits—it prolongs lifespan and restores vitality and health. However, this hasn’t always been the case. As recently as the 1980s,...
View ArticleClik here to view.
Hope for Kidney Transplant Patients Confirmed with FDA Approval of Drug...
After decades of research and testing, the FDA approves belatacept, and a new class of transplant drugs first discovered by Emory doctors. Back in September, Dr. Christian P. Larsen, Director of the...
View ArticleClik here to view.
A Life Free From Anti-Rejection Medication Post-Transplant?
A life free from taking anti-rejection medications post-transplant…is it possible? After transplant, patients must take multiple medications to keep their bodies from rejecting the new organ. The side...
View ArticleClik here to view.
Emory Receives $20 Million Grant from NIH for Continued Transplant Research
In the last few years, thanks to the development of anti-rejection drug therapies, outstanding breakthroughs in short-term outcomes have been achieved among organ transplant patients. We first...
View Article
